Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Stage IV Colorectal Cancer
NCT00041340Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2002
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in colorectal cancer (CRC), sponsored by National Cancer Institute. Started May 2002; status: completed.
02
Drugs
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00041340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041340.